Hepatitis E virus genome plasticity: a marker of chronicity and therapy failure?
Abstract
Hepatitis E virus (HEV) is a globally distributed zoonotic pathogen, spread by contaminated food and blood products, and a leading cause of acute viral hepatitis. Recent data indicate that the HEV genome contains a highly heterogeneous hypervariable region (HVR) that can tolerate extensive genomic rearrangements, especially among immunocompromised patients. These rearrangements can increase HEV replication in tissue-culture and have further been observed in HEV-infected patients. Insertions comprise either duplications of virus-derived sequences, or alternatively, host-derived sequence fragments and exhibit enrichment of specific amino acids and functional motifs. However, the molecular mechanisms driving these insertions, as well as their functional significance, remain largely unexplored. Given that sequences not required for infectivity or replication are typically rapidly eliminated in small RNA viruses such as HEV, the persistence of HVR insertions suggests a potential biological role in HEV replication and/or pathogenesis. This review summarizes our current understanding of the role of HVR insertions during HEV infection, as well as the potential mechanisms underlying these insertions. We further discuss the factors driving the selection of genomic insertions and speculate on their functional role by analyzing over 650 publicly available HEV genotype 3 genome sequences and systematically cataloging identified insertions.
Related
- Autoimmune hepatitis following long-term denosumab therapy in a patient with Hashimoto thyroiditis
- Season-adjusted longitudinal changes in serum 25-hydroxyvitamin D during pegylated interferon add-on to ongoing tenofovir alafenamide therapy in chronic hepatitis B: a real-world cohort study
- 만성 B형간염에서 Bepirovirsen 3상 임상시험: 기간 한정 치료를 통한 기능적 완치의 가능성 Phase 3 Trials of Bepirovirsen in Chronic Hepatitis B: Toward Functional Cure with Finite Therapy
- Impact of histologic hepatic steatosis on virological response to nucleos(t)ide analogue therapy in patients with chronic hepatitis B
- Established Versus Novel Strategies for Hepatitis B Functional Cure: A Cross-Regional Cost-Effectiveness Analysis of Pegylated Interferon and Bepirovirsen Add-on Therapy
BibTeX
@article{janshoff2026hepatitis,
title = {{Hepatitis E virus genome plasticity: a marker of chronicity and therapy failure?}},
author = {Saskia Janshoff and Leyla Sirkinti and Maximilian K. Nocke and Theresa S. Bechtel and André Gömer and Yannick Brüggemann and Eike Steinmann and Richard J. P. Brown and Daniel Todt},
journal = {Communications Biology},
year = {2026},
month = oct,
doi = {10.1038/s42003-026-11055-5},
url = {https://www.nature.com/articles/s42003-026-11055-5},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Hepatitis E virus genome plasticity: a marker of chronicity and therapy failure?
AU - Saskia Janshoff
AU - Leyla Sirkinti
AU - Maximilian K. Nocke
AU - Theresa S. Bechtel
AU - André Gömer
AU - Yannick Brüggemann
AU - Eike Steinmann
AU - Richard J. P. Brown
AU - Daniel Todt
PY - 2026
DA - 2026/10/22
JO - Communications Biology
DO - 10.1038/s42003-026-11055-5
UR - https://www.nature.com/articles/s42003-026-11055-5
AB - Hepatitis E virus (HEV) is a globally distributed zoonotic pathogen, spread by contaminated food and blood products, and a leading cause of acute viral hepatitis. Recent data indicate that the HEV genome contains a highly heterogeneous hypervariable region (HVR) that can tolerate extensive genomic rearrangements, especially among immunocompromised patients. These rearrangements can increase HEV replication in tissue-culture and have further been observed in HEV-infected patients. Insertions comprise either duplications of virus-derived sequences, or alternatively, host-derived sequence fragments and exhibit enrichment of specific amino acids and functional motifs. However, the molecular mechanisms driving these insertions, as well as their functional significance, remain largely unexplored. Given that sequences not required for infectivity or replication are typically rapidly eliminated in small RNA viruses such as HEV, the persistence of HVR insertions suggests a potential biological role in HEV replication and/or pathogenesis. This review summarizes our current understanding of the role of HVR insertions during HEV infection, as well as the potential mechanisms underlying these insertions. We further discuss the factors driving the selection of genomic insertions and speculate on their functional role by analyzing over 650 publicly available HEV genotype 3 genome sequences and systematically cataloging identified insertions.
SN - 2399-3642
ER -